利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

71 条记录 (耗时 0.058 秒)

    Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
    6.
    发明授权
    Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof 有权
    噻唑和其他哺乳动物多巴胺，毒蕈碱和5-羟色胺受体和转运蛋白的杂环配体及其使用方法

    公开(公告)号：US06699866B2

    公开(公告)日：2004-03-02

    申请号：US10123089

    申请日：2002-04-12

    申请人： Gregory D. Cuny ,  James R. Hauske ,  Michele L. R. Heffernan ,  Joanne M. Holland ,  Paul E. Persons ,  Heike Radeke

    发明人： Gregory D. Cuny ,  James R. Hauske ,  Michele L. R. Heffernan ,  Joanne M. Holland ,  Paul E. Persons ,  Heike Radeke

    IPC分类号： A61K31535

    CPC分类号： C07D271/07 ,  C07D277/42 ,  C07D413/12 ,  C07D417/04 ,  C07D417/06 ,  C07D417/12 ,  C07D417/14

    摘要： One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various mammalian cellular receptors, including G-protein coupled receptors. A third aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for mammalian dopamine, muscarinic or serotonin receptors or transporters. Another aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for mammalian dopamine, muscarinic or serotonin receptors. The compounds of the present invention will also find use in the treatment of numerous ailments, conditions and diseases which afflict mammals, including but not limited to addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, analgesia, schizophrenia, Parkinson's disease, restless leg syndrome, sleeping disorders, attention deficit hyperactivity disorder, irritable bowel syndrome, premature ejaculation, menstrual dysphoria syndrome, urinary incontinence, inflammatory pain, neuropathic pain, Lesche-Nyhane disease, Wilson's disease, Tourette's syndrome, psychiatric disorders, stroke, senile dementia, peptic ulcers, pulmonary obstruction disorders, and asthma.

    摘要翻译： 本发明的一个方面涉及新的杂环化合物。 本发明的第二方面涉及新型杂环化合物作为各种哺乳动物细胞受体（包括G蛋白偶联受体）的配体的用途。 本发明的第三方面涉及新型杂环化合物作为哺乳动物多巴胺，毒蕈碱或血清素受体或转运蛋白的配体的用途。 本发明的另一方面涉及新型杂环化合物作为哺乳动物多巴胺，毒蕈碱或血清素受体的配体的用途。 本发明的化合物还可用于治疗影响哺乳动物的许多疾病，病症和疾病，包括但不限于成瘾，焦虑，抑郁，性功能障碍，高血压，偏头痛，阿尔茨海默病，肥胖，呕吐，精神病 ，镇痛，精神分裂症，帕金森病，不宁腿综合征，睡眠障碍，注意力缺陷多动障碍，肠易激综合征，早泄，月经性烦躁综合征，尿失禁，炎性疼痛，神经性疼痛，Lesche-Nyhane疾病，Wilson氏病，Tourette综合征 ，精神障碍，中风，老年痴呆，消化性溃疡，肺梗阻障碍和哮喘。